Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUNDS AND MEDICAL USE THEREOF FOR COLORECTAL CANCER
Document Type and Number:
WIPO Patent Application WO/2022/174526
Kind Code:
A1
Abstract:
Provided are STAT3 small molecule inhibitors, which are naphtho[1,8-cd]isothiazol-5-one-1,1-dioxo derivatives or 1,4-dioxo-5-sulfamoyl-1,4-dihydronaphthalene derivatives. The derivatives are used for preparing medicaments for preventing and/or treating tumor-related diseases, especially colorectal cancer.

Inventors:
YU WENYING (CN)
Application Number:
PCT/CN2021/094476
Publication Date:
August 25, 2022
Filing Date:
May 19, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV CHINA PHARMA (CN)
International Classes:
C07D417/12; A61K31/4164; A61K31/495; A61K31/5377; A61K31/63; A61P35/00; C07C311/44; C07D211/26; C07D233/64; C07D241/04; C07D265/30; C07D417/00
Domestic Patent References:
WO2014028909A12014-02-20
WO2019067696A12019-04-04
Foreign References:
CN112920136A2021-06-08
CN112979578A2021-06-18
Other References:
BHASIN DEEPAK, CHETTIAR SOMSUNDARAM N., ETTER JONATHAN P., MOK MAY, LI PUI-KAI: "Anticancer activity and SAR studies of substituted 1,4-naphthoquinones", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 15, 1 August 2013 (2013-08-01), AMSTERDAM, NL, pages 4662 - 4669, XP055929299, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2013.05.017
ZHE LIU; HUAN WANG; LINGNAN GUAN; CHONG LAI; WENYING YU; MAODE LAI: "LL1, a novel and highly selective STAT3 inhibitor, displays anti‐colorectal cancer activities in vitro and in vivo", BRITISH JOURNAL OF PHARMACOLOGY, WILEY-BLACKWELL, UK, vol. 177, no. 2, 14 November 2019 (2019-11-14), UK , pages 298 - 313, XP071146573, ISSN: 0007-1188, DOI: 10.1111/bph.14863
Attorney, Agent or Firm:
NANJING ZONGHENG INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: